中文 | English
Return
Total: 122 , 1/13
Show Home Prev Next End page: GO
Author:(Guoliang YANG)

1.Advancement in bladder cancer markers in urine

Guoliang YANG ; Juanjie BO

China Oncology 2009;19(7):557-561

2.The high mobility group protein A2 and tumor

Guoliang YANG ; Juanjie BO

China Oncology 2010;20(2):156-160

3.Suspension-assisted training of motor function for patients with cerebral infarction

Guoliang YANG ; Fuzhong SI ; Zhendong LIU

Chinese Journal of Physical Medicine and Rehabilitation 2011;33(4):281-284

4.Location and expression of galactose β-1,4-glycosidic bonds in keloid tissue

Shengju YANG ; Guoliang MENG ; Xiaodong CHEN

Chinese Journal of Dermatology 2013;46(7):475-479

5.Experimental investigation and numerical simulation of air distribution in the class Ⅲ biosafety laboratory

Zonghu MA ; Guoliang NAN ; Kun YANG

Chinese Medical Equipment Journal 2004;0(09):-

6.Design and Implementation of the Outpatient Intelligent Medicine Delivery System under the Parallel New and Old Hospital Information Systems

Jian CHEN ; Guoliang YANG ; Xiuran ZUO

Journal of Medical Informatics 2016;37(6):32-35,43

7.Effects of mesenchymal stem cells intravenous transplantation on the glial cell line derived neurotrophic factor after the spinal cord injury of rats

Guoliang LI ; Jun CHEN ; Songwei YANG

Orthopedic Journal of China 2006;0(04):-

8.The questionaire of postoperative pain in the patients after maxillofacial surgery

Guoliang ZHANG ; Yurong YANG ; Bin LU

Journal of Practical Stomatology 2000;0(05):-

9.Ganle Infusion Treat Hepatitis-B of Depressed Liver and Deficient Spleen Type

Xiaojun YANG ; Guoliang ZHANG ; Weibin SHI

Journal of Zhejiang Chinese Medical University 2006;0(03):-

10.Expressions of advanced glycation end products and their receptors in keloid

Lei SHI ; Xiaodong CHEN ; Shengju YANG ; Lixiong GU ; Guoliang MENG

Chinese Journal of Dermatology 2010;43(11):780-783

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 122 , 1/13 Show Home Prev Next End page: GO